Vo DD - Search Results

1

Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.

Tran TP, Vo DD, Di Giorgio A, Duca M. Tran TP, et al. Among authors: vo dd. Bioorg Med Chem. 2015 Sep 1;23(17):5334-44. doi: 10.1016/j.bmc.2015.07.062. Epub 2015 Jul 30. Bioorg Med Chem. 2015. PMID: 26264847

2

Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.

Vo DD, Duca M. Vo DD, et al. Methods Mol Biol. 2017;1517:137-154. doi: 10.1007/978-1-4939-6563-2_10. Methods Mol Biol. 2017. PMID: 27924480

3

Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.

Vo DD, Staedel C, Zehnacker L, Benhida R, Darfeuille F, Duca M. Vo DD, et al. ACS Chem Biol. 2014 Mar 21;9(3):711-21. doi: 10.1021/cb400668h. Epub 2014 Jan 3. ACS Chem Biol. 2014. PMID: 24359019

4

Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.

Vo DD, Tran TP, Staedel C, Benhida R, Darfeuille F, Di Giorgio A, Duca M. Vo DD, et al. Chemistry. 2016 Apr 4;22(15):5350-62. doi: 10.1002/chem.201505094. Epub 2016 Mar 1. Chemistry. 2016. PMID: 26928593

5

Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.

Vo DD, Becquart C, Tran TPA, Di Giorgio A, Darfeuille F, Staedel C, Duca M. Vo DD, et al. Org Biomol Chem. 2018 Aug 29;16(34):6262-6274. doi: 10.1039/c8ob01858h. Org Biomol Chem. 2018. PMID: 30116813

6

Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis.

Maucort C, Vo DD, Aouad S, Charrat C, Azoulay S, Di Giorgio A, Duca M. Maucort C, et al. Among authors: vo dd. ACS Med Chem Lett. 2021 May 14;12(6):899-906. doi: 10.1021/acsmedchemlett.0c00682. eCollection 2021 Jun 10. ACS Med Chem Lett. 2021. PMID: 34141067 Free PMC article.

7

Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells.

Vo DD, Gautier F, Barillé-Nion S, Juin P, Levoin N, Grée R. Vo DD, et al. Bioorg Med Chem Lett. 2014 Apr 1;24(7):1758-61. doi: 10.1016/j.bmcl.2014.02.035. Epub 2014 Feb 24. Bioorg Med Chem Lett. 2014. PMID: 24602902

8

A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.

Levoin N, Vo DD, Gautier F, Barillé-Nion S, Juin P, Tasseau O, Grée R. Levoin N, et al. Among authors: vo dd. Bioorg Med Chem. 2015 Apr 15;23(8):1747-57. doi: 10.1016/j.bmc.2015.02.060. Epub 2015 Mar 6. Bioorg Med Chem. 2015. PMID: 25797160 Free article.

9

Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity.

Praveen Kumar V, Gajendra Reddy R, Vo DD, Chakravarty S, Chandrasekhar S, Grée R. Praveen Kumar V, et al. Among authors: vo dd. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1439-44. doi: 10.1016/j.bmcl.2011.12.015. Epub 2011 Dec 9. Bioorg Med Chem Lett. 2012. PMID: 22209461

10

Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction.

Vo DD, Gautier F, Juin P, Grée R. Vo DD, et al. Eur J Med Chem. 2012 May;51:286-93. doi: 10.1016/j.ejmech.2012.02.036. Epub 2012 Feb 25. Eur J Med Chem. 2012. PMID: 22425031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters